Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Arbutus Biopharma Corporation (ABUS)

3.13   -0.05 (-1.57%) 09-30 17:00
Open: 3.17 Pre. Close: 3.18
High: 3.2 Low: 3.06
Volume: 837,032 Market Cap: 263M
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, British Columbia and currently employs 80 full-time employees. The firm is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The firm develops a portfolio of drug candidates with multiple mechanisms of action that results in a combination therapy to cure HBV. In addition to its HBV pipeline, the Company actively licenses its Lipid Nanoparticle (LNP) technology to its industry partners. This technology represents a delivery technology in RNA interference (RNAi) therapeutic development, which has enabled several clinical trials and has been administered to hundreds of human subjects.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.207 - 3.223 3.223 - 3.236
Low: 3.017 - 3.038 3.038 - 3.055
Close: 3.1 - 3.132 3.132 - 3.159

Technical analysis

as of: 2020-09-30 4:38:13 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.96     One year: 4.62
Support: Support1: 2.72    Support2: 2.31
Resistance: Resistance1: 3.39    Resistance2: 3.96
Pivot: 2.91
Moving Average: MA(5): 3.07     MA(20): 2.82
MA(100): 2.66     MA(250): 2.26
MACD: MACD(12,26): 0.02     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 73.82     %D(3): 70.41
RSI: RSI(14): 55.13
52-week: High: 9.02  Low: 0.82  Change(%): 118.9
Average Vol(K): 3-Month: 969025  10-Days: 169161

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ABUS has closed below upper band by 27.6%. Bollinger Bands are 32% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 30 Sep 2020
Is Arbutus Biopharma Corporation (ABUS) a Keeper? - The News Heater

Wed, 30 Sep 2020
An in-depth look at the Arbutus Biopharma Corporation (ABUS) stock - Marketing Sentinel

Mon, 28 Sep 2020
Is It the fundamentals that draw people into Arbutus Biopharma Corporation [ABUS] - MZP News

Sun, 27 Sep 2020
$1.81 Million in Sales Expected for Arbutus Biopharma Corp (NASDAQ:ABUS) This Quarter - MarketBeat

Thu, 24 Sep 2020
Recent Change of -2.97% in the Arbutus Biopharma Corporation (ABUS) market price might lead to pleasant surprises - The InvestChronicle

Wed, 23 Sep 2020
Arbutus Biopharma Corporation (ABUS) latest performance of 0.00% is not what was on cards - News Daemon

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 83
Shares Float (M) 51
% Held by Insiders 30.16
% Held by Institutions 35.04
Shares Short (K) 2,620
Shares Short P. Month (K) 1,970

Stock Financials

EPS -2.319
EPS Est This Year -1.390
EPS Est Next Year -1.350
Book Value (p.s.) -1.090
Profit Margin
Operating Margin -749.69
Return on Assets (ttm) -24.8
Return on Equity (ttm) -117.5
Qtrly Rev. Growth 131.9
Gross Profit (p.s.) -0.622
Sales Per Share 0.093
EBITDA (p.s.) -0.670
Qtrly Earnings Growth
Operating Cash Flow (M) -61
Levered Free Cash Flow (M) -34

Stock Valuations

PE Ratio -1.35
PEG Ratio
Price to Book value -2.87
Price to Sales 33.79
Price to Cash Flow -4.25

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.